Publication date: Jul 06, 2025
Understanding how hospital length of stay (LoS) evolves with successive SARS-CoV-2 variants is central to the multiscale modeling and forecasting of COVID-19 and other respiratory virus dynamics. Using records from 1249 COVID-19 patients admitted to Chungbuk National University Hospital (2021-2023), we quantified LoS across three distinct variant phases (Pre-Delta, Delta, and Omicron) and three age groups (0-39, 40-64, and 65+ years). A gamma-distributed multi-state model-capturing transitions between semi-critical and critical wards-incorporated variant phase and age as log-linear covariates. Parameters were estimated via maximum likelihood with 95% confidence intervals derived from bootstrap resampling, and Monte Carlo iterations yielded detailed LoS distributions. Omicron-phase stays were 5-8 days, shorter than the 10-14 days observed in earlier phases, reflecting improved treatment protocols and reduced virulence. Younger adults typically stayed 3-5 days, whereas older cohorts required 8-12 days, with prolonged admissions (over 30 days) clustering in the oldest group. These time-dependent transition probabilities can be integrated with real-time bed-availability alert systems, highlighting the need for variant-specific ward/ICU resource planning and underscoring the importance of targeted management for elderly patients during current and future pandemics.

Open Access PDF
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| disease | IDO | virulence |
| drug | DRUGBANK | Etodolac |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | immunocompromised patients |
| disease | MESH | death |
| disease | MESH | Uncertainty |
| disease | MESH | infection |
| disease | MESH | critically ill |
| disease | IDO | process |
| disease | IDO | history |
| disease | IDO | pathogen |
| disease | MESH | influenza |
| disease | MESH | comorbidity |
| drug | DRUGBANK | Serine |
| disease | MESH | emergency |
| disease | MESH | cardiac arrest |
| drug | DRUGBANK | Troleandomycin |
| drug | DRUGBANK | Guanosine |
| disease | MESH | clinical significance |
| drug | DRUGBANK | Water |
| disease | IDO | algorithm |
| disease | IDO | intervention |
| drug | DRUGBANK | Naproxen |
| disease | MESH | pneumonia |